iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Position Lessened by JPMorgan Chase & Co.

JPMorgan Chase & Co. decreased its stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 30.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 8,282 shares of the company’s stock after selling 3,690 shares during the period. JPMorgan Chase & Co. owned 0.08% of iShares U.S. Pharmaceuticals ETF worth $585,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in IHE. EP Wealth Advisors LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $157,000. Jane Street Group LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 5.5% during the 3rd quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after acquiring an additional 616 shares in the last quarter. Pinnacle Family Advisors LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 75.8% during the 3rd quarter. Pinnacle Family Advisors LLC now owns 11,595 shares of the company’s stock valued at $819,000 after acquiring an additional 5,000 shares in the last quarter. Flow Traders U.S. LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $839,000. Finally, FMR LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 10.9% during the 3rd quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after acquiring an additional 1,338 shares in the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of iShares U.S. Pharmaceuticals ETF stock opened at $69.71 on Tuesday. The business’s fifty day moving average price is $67.12 and its two-hundred day moving average price is $69.04. The company has a market capitalization of $704.07 million, a P/E ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a 1-year low of $62.67 and a 1-year high of $72.94.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.